Oraliva, Inc.
Publicly observedNaples, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Naples | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Oraliva, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | LMZ2DG9M4RH6 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant1 Sept 2025Publicly observed
NIH SBIR/STTR award: Point of care diagnostic to improve access to gynecological screening in low-resource settings
USD 400,000.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
- Grant15 Apr 2025Publicly observed
NIH SBIR/STTR award: AI-linked cytomics-on-a-chip to enable near-real time identification and management of oral lichenoid lesions in primary care
USD 697,404.00 · National Institute of Dental and Craniofacial Research · Source: NIH RePORTER (opens in a new tab)
- Grant15 Apr 2025Publicly observed
NIH SBIR/STTR award: AI-linked cytomics-on-a-chip to enable near-real time identification and management of oral lichenoid lesions in primary care
USD 1,178,476.00 · National Institute of Dental and Craniofacial Research · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.